Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world?
We will send you informative information from time to time so you can learn about cannabis and if it can help you.
Cymra Life Sciences is focused on genetics and pharmaceutical drug development for international and domestic markets.
Cymra holds both cultivation and manufacturing licences from the Australian of Office of Drug Control. We have a site in Northern NSW that has already commenced a breeding program on low THC genetics and will be able to supply cultivators once permitted
Cymra is already distributing medical cannabis products in Australia but is also developing products in chronic pain and associated conditions to make to market domestically and internationally. We’re currently working to develop a locally cultivated full spectrum medical cannabis products through our supply chain partners.
If you are interested in a discussion around investing please contact us for a discussion.
We have 5 key focus areas which we refer to as our strategic pillars
Genetic Licensing Program
Tissue Culture Services
One of Australia’s largest cannabis genetic libraries
Focus on high value parts of value chain.
Construction & retrofit of Northern Rivers Facility
Distribution Revenue and sales infrastructure
Value add by developing proprietary drug
Experienced pharma + medical team
Clinical Development Pathway